Learning in Silico: 21st Century Product Development
Jonathan C. Peck, Institute for Alternative Futures, Alexandria, Virginia
In this presentation forecasts will describe how artificial intelligence, eHealth, virtual organs and in silico biology can affect development and regulation over the next two decades. The focus will be on anticipating impacts from new knowledge and technology on pre-clinical, clinical and post-market studies for pharmaceuticals, biologics and devices. The thesis is that progress in multiple fields will enrich models and simulations with knowledge that will predict safety and efficacy issues with growing accuracy. Forecasts will describe new capabilities - from high-throughput screens using "androids" to implanted "biomems" sensors - emerging along with computer simulations to offer new ways to know when products will be safe and effective.